NASDAQ
LEXXW

Lexaria Bioscience Corp

Prices are adjusted according to historical splits.

Lexaria Bioscience Corp Stock Price

Vitals

Today's Low:
$0.1914
Today's High:
$0.21
Open Price:
$0.21
52W Low:
$0.0732
52W High:
$0.9266
Prev. Close:
$0.16
Volume:
0

Company Statistics

Market Cap.:
$33.79 million
Book Value:
Revenue TTM:
$669867
Operating Margin TTM:
-544.7%
Gross Profit TTM:
$0
Profit Margin:
0%
Return on Assets TTM:
-92.7%
Return on Equity TTM:
-3437.57%

Company Profile

Lexaria Bioscience Corp had its IPO on 2021-01-12 under the ticker symbol LEXXW.

The company operates in the sector and industry. Lexaria Bioscience Corp has a staff strength of 4 employees.

Stock update

Shares of Lexaria Bioscience Corp opened at $0.21 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.19 - $0.21, and closed at $0.2.

This is a +24.94% increase from the previous day's closing price.

A total volume of 0 shares were traded at the close of the day’s session.

In the last one week, shares of Lexaria Bioscience Corp have slipped by -16.67%.

Lexaria Bioscience Corp's Key Ratios

Lexaria Bioscience Corp has a market cap of $33.79 million, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Lexaria Bioscience Corp’s revenue was $669867 with a gross profit of $0 and an EBITDA of $-3535628. The EBITDA ratio measures Lexaria Bioscience Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Lexaria Bioscience Corp’s operating margin was -544.7% while its return on assets stood at -92.7% with a return of equity of -3437.57%.

In Q2, Lexaria Bioscience Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 2761.6%.

Lexaria Bioscience Corp’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Lexaria Bioscience Corp’s profitability.

Lexaria Bioscience Corp stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

Lexaria Bioscience Corp stock pays annual dividends of $ per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$5.24 million
Total Liabilities
$1.06 million
Operating Cash Flow
$0
Capital Expenditure
$33647
Dividend Payout Ratio
0%

Lexaria Bioscience Corp ended 2024 with $5.24 million in total assets and $0 in total liabilities. Its intangible assets were valued at $5.24 million while shareholder equity stood at $4.40 million.

Lexaria Bioscience Corp ended 2024 with $0 in deferred long-term liabilities, $1.06 million in other current liabilities, 8091.00 in common stock, $-44524108.00 in retained earnings and $0 in goodwill. Its cash balance stood at $3.16 million and cash and short-term investments were $3.43 million. The company’s total short-term debt was $32,317 while long-term debt stood at $0.

Lexaria Bioscience Corp’s total current assets stands at $4.24 million while long-term investments were $0 and short-term investments were $269560.00. Its net receivables were $172284.00 compared to accounts payable of $1.01 million and inventory worth $0.

In 2024, Lexaria Bioscience Corp's operating cash flow was $0 while its capital expenditure stood at $33647.

Comparatively, Lexaria Bioscience Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.2
52-Week High
$0.9266
52-Week Low
$0.0732
Analyst Target Price
$

Lexaria Bioscience Corp stock is currently trading at $0.2 per share. It touched a 52-week high of $0.9266 and a 52-week low of $0.9266. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.25 and 200-day moving average was $0.47 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Lexaria Bioscience Corp

The stock symbol (also called stock or share ticker) of Lexaria Bioscience Corp is LEXXW

The IPO of Lexaria Bioscience Corp took place on 2021-01-12

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries. Lexaria Bioscience Corp. was founded in 2004 and is headquartered in Kelowna, Canada.

Address

100 ? 740 McCurdy Road, Kelowna, BC, Canada, V1X 2P7